首頁 > 市場調查報告書 > 製藥

生物製劑基因治療學和RNAi 分子標靶治療學

市場調查報告書

商品編碼

1378999

適體市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Aptamers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球適配體市場規模達21億美元。展望未來， IMARC Group預計到2028年市場規模將達到65億美元，2022-2028年複合年成長率（CAGR）為20.7%。

適體是多功能寡核苷酸，可與特定標靶結合，包括蛋白質、勝肽、碳水化合物、小分子、毒素和活細胞。與抗體相比，它們具有可修飾性、非免疫原性、敏感性高、毒性低、易於製備、分子量低且不同製劑不存在差異等特點。因此，它們被廣泛用於治療和生物技術應用。除此之外，它們還被用作研究劑、診斷劑、生物感測器以及全球生物標記或藥物發現的工具。

全球適體市場趨勢：

癌症、神經退化性疾病、心血管疾病和後天免疫缺乏症候群（愛滋病）等危及生命的疾病的日益流行，是影響基於適體療法的新型有效檢測方法需求的關鍵因素之一。此外，增加核酸酶抗性並增強適體治療特性的化學修飾製程的出現正在推動市場成長。適配體市場的成長也可以歸因於為改善診斷設備和藥物及其載體而進行的研發（R&D）活動數量的增加。除此之外，由於適配體是化學合成的，消除了批次之間的差異並且需要更少的開發時間，因此它們的應用在全球範圍內廣泛增加。此外，私人組織正在與學術機構和研究實驗室合作，推出下一代產品並擴大其現有的市場佔有率。預計這將推動適體在廣泛的醫學治療以及食品和飲料 (F&B) 行業中的使用。

本報告回答的關鍵問題：

迄今為止，全球適配體市場表現如何，未來幾年將如何表現？
COVID-19對全球適配體市場有何影響？
主要區域市場有哪些？
依類型分類市場是怎麼樣的？
基於應用程式的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球適配體市場結構如何？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 9 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 12 章：價格分析

第13章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Aptagen LLC
- Aptamer Group
- Aptamer Sciences Inc.
- Aptus Biotech SL
- Base Pair Biotechnologies Inc.
- IBA GmbH
- Kaneka Eurogentec SA (Kaneka Corporation)
- NeoVentures Biotechnology Inc.
- NOXXON Pharma
- SomaLogic Inc.
- TriLink BioTechnologies LLC
- Vivonics Inc.

簡介目錄圖表

Product Code: SR112023A3845

Abstract

The global aptamers market size reached US$ 2.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2028, exhibiting a growth rate (CAGR) of 20.7% during 2022-2028.

Aptamers are versatile oligonucleotides that bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and live cells. They are modifiable, nonimmunogenic, highly sensitive, less toxic, easy to prepare and have low molecular weight and no variation with different preparations as compared to antibodies. As a result, they are widely being used in therapeutic and biotechnological applications. Besides this, they are also utilized as research agents, diagnostics, biosensors, and tools for biomarker or drug discovery worldwide.

Global Aptamers Market Trends:

The growing prevalence of life-threatening diseases, such as cancer, neurodegenerative, cardiovascular, and acquired immunodeficiency syndrome (AIDS), represents one of the key factors influencing the demand for new and effective detection assays based on aptamer therapy. Moreover, the advent of the chemical modification process to increase the nuclease resistance and enhance the therapeutic properties of aptamers is bolstering the market growth. The aptamers market growth can also be accredited to the rising number of research and development (R&D) activities undertaken for improving diagnostic devices and drugs and their carriers. Apart from this, as aptamers are chemically synthesized, which eliminates batch-to-batch variation and requires less time for development, their application is extensively increasing across the globe. Furthermore, private organizations are collaborating with academic institutes and research laboratories to introduce next-generation products and expand their existing market presence. This is anticipated to fuel the usage of aptamers in a wide range of medical therapies, as well as in the food and beverage (F&B) industry.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global aptamers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type and application.

Breakup by Type:

Nucleic Acid

Peptide

Breakup by Application:

Diagnostics

Therapeutics

Research and Developments

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aptagen LLC, Aptamer Group, Aptamer Sciences Inc., Aptus Biotech S.L., Base Pair Biotechnologies Inc., IBA GmbH, Kaneka Eurogentec S.A. (Kaneka Corporation), NeoVentures Biotechnology Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies LLC and Vivonics Inc.

Key Questions Answered in This Report:

How has the global aptamers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global aptamers market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global aptamers market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Aptamers Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Nucleic Acid
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Peptide
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Application

7.1 Diagnostics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Therapeutics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Research and Developments
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Aptagen LLC
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
- 13.3.2 Aptamer Group
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
- 13.3.3 Aptamer Sciences Inc.
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
- 13.3.4 Aptus Biotech S.L.
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
- 13.3.5 Base Pair Biotechnologies Inc.
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
- 13.3.6 IBA GmbH
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
- 13.3.7 Kaneka Eurogentec S.A. (Kaneka Corporation)
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
- 13.3.8 NeoVentures Biotechnology Inc.
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
- 13.3.9 NOXXON Pharma
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
- 13.3.10 SomaLogic Inc.
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
- 13.3.11 TriLink BioTechnologies LLC
  - 13.3.11.1 Company Overview
  - 13.3.11.2 Product Portfolio
- 13.3.12 Vivonics Inc.
  - 13.3.12.1 Company Overview
  - 13.3.12.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Aptamers Market: Major Drivers and Challenges
Figure 2: Global: Aptamers Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Aptamers Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Aptamers Market: Breakup by Type (in %), 2022
Figure 5: Global: Aptamers Market: Breakup by Application (in %), 2022
Figure 6: Global: Aptamers Market: Breakup by Region (in %), 2022
Figure 7: Global: Aptamers (Nucleic Acid) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Aptamers (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Aptamers (Peptide) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Aptamers (Peptide) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Aptamers (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Aptamers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Aptamers (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Aptamers (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Aptamers (Research and Developments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Aptamers (Research and Developments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Aptamers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Aptamers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: North America: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: North America: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: United States: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: United States: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Canada: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Canada: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Asia-Pacific: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Asia-Pacific: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: China: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: China: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Japan: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Japan: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: India: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: India: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: South Korea: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: South Korea: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Australia: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Australia: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Indonesia: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Indonesia: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Others: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Europe: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Europe: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Germany: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Germany: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: France: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: France: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: United Kingdom: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: United Kingdom: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Italy: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Italy: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Spain: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Spain: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Russia: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Russia: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Latin America: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Latin America: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Brazil: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Brazil: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Mexico: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Mexico: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Middle East and Africa: Aptamers Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Middle East and Africa: Aptamers Market: Breakup by Country (in %), 2022
Figure 67: Middle East and Africa: Aptamers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Global: Aptamers Industry: SWOT Analysis
Figure 69: Global: Aptamers Industry: Value Chain Analysis
Figure 70: Global: Aptamers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Aptamers Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Aptamers Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Aptamers Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Aptamers Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Aptamers Market: Competitive Structure
Table 6: Global: Aptamers Market: Key Players

02-2729-4219

+886-2-2729-4219